Titan Pharmaceuticals, Inc. (de) [TTNP] stock prices are up 21.94% to $3.84 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TTNP shares have gain 14.82% over the last week, with a monthly amount glided 13.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Titan Pharmaceuticals, Inc. (de) [NASDAQ: TTNP] stock has seen the most recent analyst activity on June 26, 2019, when Maxim Group initiated its Buy rating and assigned the stock a price target of $4. Previously, ROTH Capital downgraded its rating to Neutral on November 10, 2017.
The stock price of Titan Pharmaceuticals, Inc. (de) [TTNP] has been fluctuating between $3.03 and $14.80 over the past year. Titan Pharmaceuticals, Inc. (de) [NASDAQ: TTNP] shares were valued at $3.84 at the most recent close of the market.
Analyzing the TTNP fundamentals
The Titan Pharmaceuticals, Inc. (de) [NASDAQ:TTNP] reported sales of 0.00M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -71.88%, Pretax Profit Margin comes in at -72.67%, and Net Profit Margin reading is -72.67%. To continue investigating profitability, this company’s Return on Assets is posted at -1.63, Equity is -1.18 and Total Capital is -1.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.33 points at the first support level, and at 2.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.15, and for the 2nd resistance point, it is at 4.47.
Ratios To Look Out For
It’s worth pointing out that Titan Pharmaceuticals, Inc. (de) [NASDAQ:TTNP]’s Current Ratio is 9.71. Also, the Quick Ratio is 9.71, while the Cash Ratio stands at 9.16.
